BlackRock Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$281M Buy
2,426,361
+400,801
+20% +$44.6M 0.3% 83
2016
Q3
$212M Sell
2,025,560
-183,564
-8% -$19.9M 0.23% 115
2016
Q2
$218M Sell
2,209,124
-1,830,019
-45% -$189M 0.24% 106
2016
Q1
$404M Buy
4,039,143
+422,771
+12% +$43.5M 0.44% 53
2015
Q4
$433M Buy
3,616,372
+30,629
+0.9% +$3.54M 0.47% 52
2015
Q3
$388M Buy
3,585,743
+1,391,238
+63% +$173M 0.43% 62
2015
Q2
$254M Sell
2,194,505
-265,286
-11% -$30.3M 0.28% 98
2015
Q1
$284M Sell
2,459,791
-323,174
-12% -$38.6M 0.3% 88
2014
Q4
$311M Buy
2,782,965
+1,567
+0.1% +$165K 0.33% 78
2014
Q3
$264M Sell
2,781,398
-220,498
-7% -$19.9M 0.27% 94
2014
Q2
$258M Sell
3,001,896
-84,488
-3% -$6.43M 0.25% 107
2014
Q1
$215M Sell
3,086,384
-1,489,774
-33% -$118M 0.21% 121
2013
Q4
$387M Sell
4,576,158
-1,739,198
-28% -$138M 0.38% 66
2013
Q3
$487M Buy
6,315,356
+849,332
+16% +$59.5M 0.5% 49
2013
Q2
$320M Buy
+5,466,024
New +$329M 0.34% 74

Other funds holding CELG